phrykt

Moderna (MRNA) debt: $590M

Moderna had $590M of long-term debt on Dec 31, 2025, including the part due within a year.

From Moderna's filings with the SEC · Read the filing · MRNA stock page

Moderna debt by year

$590M2025

#1,062 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$590M–

Debt of similar companies

Companies in the same industry as Moderna, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Halozyme Therapeutics$2.1BDec 31, 2025
Qiagen$1.7BDec 31, 2025
Moderna$590MDec 31, 2025
Repligen$542MDec 31, 2025
Novavax$244MDec 31, 2025
Adaptive Biotechnologies$131MDec 31, 2025
Inhibrx Biosciences$101MDec 31, 2025

Questions and answers

What is Moderna's debt?

Moderna had $590M of long-term debt on Dec 31, 2025, including the part due within a year.

Numbers as reported in Moderna's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology